Assessing the impact of NICE guidance on the prescribing of hormonal treatments of breast cancer in England

E-ISSN： 1365-2753|21|4|759-761

ISSN： 1356-1294

Source： JOURNAL OF EVALUATION IN CLINICAL PRACTICE (ELECTRONIC), Vol.21, Iss.4, 2015-08, pp. : 759-761

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Assessing the risk of bone fracture among postmenopausal women who are receiving adjuvant hormonal therapy for breast cancer

By Bell R. Lewis J.

Current Medical Research and Opinion, Vol. 23, Iss. 5, 2007-05 ,pp. : 1045-1051

Informa Healthcare

Access to resources Recommend Favorite

New treatments in breast cancer management

By Dean Antonia

Community Practitioner, Vol. 80, Iss. 6, 2007-06 ,pp. : 40-42

Community Practitioner

Access to resources Recommend Favorite

Hormonal Treatment of Breast Cancer: New Developments

Oncology, Vol. 55, Iss. 6, 1998-10 ,pp. : 501-507

Karger

Access to resources Recommend Favorite

Prediction of Response to Hormonal Treatment in Metastatic Breast Cancer

Oncology, Vol. 63, Iss. 4, 2002-11 ,pp. : 309-316

Karger

Access to resources Recommend Favorite

Hormonal Therapy in Postmenopausal Women with Breast Cancer

Oncology, Vol. 64, Iss. 4, 2003-05 ,pp. : 289-299

Karger

Access to resources Recommend Favorite